ArticleFrontiers in oncology2025

Pembrolizumab versus bevacizumab plus modified FOLFOX6 in metastatic MSI-H/dMMR colorectal cancer: a multicenter retrospective study with CT evaluation.

Jiaqi Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.